Four Boston Biotechs That Could Make M&A Moves This Year
PAREXEL International (PRXL) Stays Mum as 200 Ex-GlaxoSmithKline (GSK) Workers are Reportedly Being Laid Off Today
New Jersey is Competitive in Biotech, But Falls Behind Boston and Bay Area
Ex-Vertex (VRTX) Digs Get Two New Biotech Tenants in CRISPR and Synologic
Sanofi (SNY)'s Q2 Report Card: Did New CEO's Hard Work Pay Off?
After Cutting 150 Ranbaxy Laboratories (RANBAXY.BO) Execs, Sun Pharma (SUNPHARMA.NS) Takes the Ax to Some R&D Workers
Spotted: Big Life Science Names Party at Takeda (TKPYY)'s Cambridge Courtyard
GlaxoSmithKline (GSK) CEO Confident Investors Will Be Pleased With Pipeline on Nov. R&D Day
GlaxoSmithKline (GSK) Just Got Over China Scandal But New Corruption Allegations Emerge
Step Aside Juno (JUNO): World's Richest Doctor Pulls Off Largest Biotech IPO Ever
Pfizer (PFE) CEO on the Prowl for New Acquisitions
Pfizer (PFE) Pulls Plug on OTC Lipitor After Trial Failure
Allergan (AGN) Could Set its Sights on Another Transformative M&A Deal With Biogen (BIIB), Amgen (AMGN) or AbbVie (ABBV)
Mereo Launches With $119 Million, Three Drugs from Novartis AG (NVS) and a Partnership with ICON
BioPharm Executive: Why Some Drugmakers May See Their Profits Slashed
Takeover Target or Potential Buyer? Analysts Speculate on Biogen (BIIB)’s Future After Big Stock Drop
Biogen (BIIB) Chairman Reassures Investors With $3 Million Stock Buy
PDL BioPharma (PDLI) to Infuse Up to $200 Million Into Troubled Ariad (ARIA)
See All News >
Step Aside Juno (JUNO): World's Richest Doctor Pulls Off Largest Biotech IPO Ever
Pfizer (PFE) CEO on the Prowl for New Acquisitions
Pfizer (PFE) Pulls Plug on OTC Lipitor After Trial Failure
Allergan (AGN) Could Set its Sights on Another Transformative M&A Deal With Biogen (BIIB), Amgen (AMGN) or AbbVie (ABBV)
Takeover Target or Potential Buyer? Analysts Speculate on Biogen (BIIB)’s Future After Big Stock Drop
Biogen (BIIB) Chairman Reassures Investors With $3 Million Stock Buy
PDL BioPharma (PDLI) to Infuse Up to $200 Million Into Troubled Ariad (ARIA)
Merck & Co. (MRK) Snaps up Israel Oncology Firm cCam Biotherapeutics for $605 Million
Sanofi (SNY)'s Lixilan Hits Phase III Goal
Deerfield Management Launches $550 Million Biotech Fund
Sanofi (SNY) and Regeneron (REGN) Ink $2.2 Billion Immuno-Oncology, PD-1 Inhibitor Deal
Analysts Wait With Bated Breath for Gilead (GILD) Q2 Results, Possible Acquisition News
Allergan (AGN) Considers Breaking Up Into Two Businesses Months After Actavis (ACT) Merger
Progenics Pharmaceuticals, Inc. (PGNX) Announces Breakthrough Therapy Designation for Azedra in Pheochromocytoma And Paraganglioma
FibroGen, Inc. (FGEN) Receives FDA Clearance to Proceed With Clinical Study of FG-3019 in Duchenne Muscular Dystrophy
Mallinckrodt (MNK) Divests Contrast Media Biz to Guerbet (GBT) For $270 Million
Report Shows Gilead (GILD) Creates $3.5 Million per Employee
When Her Daughter Was Diagnosed With A Rare Disease, This Accountant Started A Biotech
See All News >
//-->